Posard Matthew L. sold HALO
October 1, 2026 · Form 4 insider transaction
Posard Matthew L. sold 100 shares of Halozyme Therapeutics, Inc. at $110.04 per share, a transaction worth $11.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$110.04
Total value
$11.0K
InsiderPosard Matthew L.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after53,609
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 15, 2026 in accordance with Rule 10b5-1.